Address Unmet Measurement Needs in Parkinson’s Disease with Wearable DHTs

Sensor-based DHTs are shedding an illuminating light on how people function in their real-world environments. Drug developers, researchers, patients, and regulators are realizing the multifaceted value sensor-based DHTs can bring to clinical research.

Patients with Parkinson’s disease (PD) experience symptoms that are highly variable day-to-day and between individuals. Continuous, real-world data from low-burden wearable devices can enable more objective and sensitive measures to adequately capture disease fluctuations and progression over time for clinical researchers studying and developing treatments for movement disorders such as Parkinson’s disease, Huntington’s disease, and Essential Tremor.    

In this 45-minute webinar, we’ll discuss the unique challenges for researchers and drug developers studying Parkinson's Disease, share the current state-of-the-art wearable DHT solutions and how they can help overcome challenges to advance treatments for this group of patients.

• Understanding cardinal symptoms of Parkinson’s disease
• Discuss the limitations of existing clinical scales and research efforts in leveraging DHTs
• Deep dive into clinically validated algorithms using continuous, remotely collected wearable DHT data to characterize symptoms in the real-world

Join industry experts in this moderated discussion:

• Fatta B. Nahab, MD FAAN FANA, Executive Director, Clinical and Digital Development, Neuron23

• Karen Krygier, MBA, Digital Health Consultant, PKG Health

• Christine Guo, PhD, Chief Scientific Officer and Moderator, Actigraph

Register here.